Hepatology

In a northern Mexico cohort, MASLD now accounts for the largest share of chronic liver disease and cirrhosis cases.

Normothermic machine perfusion allows clinicians to assess high-risk livers from donors after circulatory or brain death before transplantation.

Sudan faces an outbreak of acute hepatitis among displaced populations, with severe liver complications in vulnerable communities.

Obesity drives liver disease progression, with new therapies and weight-loss strategies offering hope for improved outcomes in MASLD and MASH.

Advanced chronic liver disease is driven by portal hypertension. Explore how beta-blockers like carvedilol may help manage risk and delay decompensation.

The FIB-4 index may not reliably detect liver fibrosis in MASLD, with high false-positive and false-negative rates, highlighting challenges for primary care screening.

Menstrual recovery after liver transplantation may indicate better graft liver health, as women whose periods returned were far less likely to develop liver complications.

New study finds cfDNA fragmentome analysis can detect liver disease early, identify fibrosis and cirrhosis, and even predict survival across illnesses.